CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.286
+0.011 (0.82%)
Jul 28, 2026, 8:00 AM GMT
CelLBxHealth Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.15 | 1.35 | 2.86 | 2.19 | 1.04 | 1.01 | |
Revenue Growth | -14.73% | -52.80% | 30.92% | 109.99% | 2.76% | 32.94% |
Cost of Revenue | 0.42 | 0.52 | 1.08 | 0.66 | 0.43 | 0.3 |
Gross Profit | 0.73 | 0.83 | 1.78 | 1.53 | 0.61 | 0.71 |
Other Operating Expenses | 14.08 | 21.04 | 16.88 | 23.29 | 24.82 | 17.99 |
Total Operating Expenses | 14.08 | 21.04 | 16.88 | 23.29 | 24.82 | 17.99 |
Operating Income | -12.22 | -19.25 | -15.1 | -21.76 | -24.21 | -17.24 |
Interest Income | 0.08 | 0.13 | 0.4 | 0.46 | 0.14 | 0.03 |
Interest Expense | -0.2 | -0.29 | -0.33 | -0.34 | -0.37 | -0.16 |
Total Non-Operating Income (Expense) | -0.12 | -0.16 | 0.07 | 0.13 | -0.23 | -0.13 |
Pretax Income | -12.35 | -19.41 | -15.03 | -21.63 | -24.44 | -17.36 |
Provision for Income Taxes | -0.6 | -0.1 | 0.8 | 1.5 | 2.75 | 2.35 |
Net Income | -11.75 | -19.31 | -15.83 | -20.13 | -21.69 | -15.01 |
Net Income to Common | -11.75 | -19.31 | -15.83 | -20.13 | -21.69 | -15.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 891 | 354 | 295 | 260 | 247 | 225 |
Shares Outstanding (Diluted) | 891 | 354 | 295 | 260 | 247 | 225 |
Shares Change | 151.74% | 19.97% | 13.23% | 5.63% | 9.55% | 26.42% |
EPS (Basic) | -0.01 | -0.06 | -0.05 | -0.08 | -0.09 | -0.07 |
EPS (Diluted) | -0.01 | -0.06 | -0.05 | -0.08 | -0.09 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.83 | -9.48 | -13.86 | -15.07 | -17.77 | -15.68 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.01 | -0.03 | -0.05 | -0.06 | -0.07 | -0.07 |
Gross Margin | 63.37% | 61.58% | 62.16% | 69.90% | 58.89% | 70.19% |
Operating Margin | -1061.02% | -1424.80% | -527.46% | -995.38% | -2325.36% | -1701.38% |
Profit Margin | -1019.79% | -1429.09% | -553.21% | -920.95% | -2083.19% | -1481.93% |
FCF Margin | -766.06% | -701.63% | -484.24% | -689.34% | -1706.82% | -1547.48% |
EBITDA | -6.77 | -13.63 | -13.4 | -19.45 | -21.37 | -15.75 |
EBITDA Margin | -587.50% | -1008.59% | -468.13% | -889.80% | -2052.74% | -1554.59% |
EBIT | -12.22 | -19.25 | -15.1 | -21.76 | -24.21 | -17.24 |
EBIT Margin | -1061.02% | -1424.80% | -527.46% | -995.38% | -2325.36% | -1701.38% |
Effective Tax Rate | 4.84% | 0.52% | -5.35% | -6.93% | -11.26% | -13.54% |